Copertina

Analysis of related factors of CRA in lung cancer patients with different serum iron levels: A retrospective cohort study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Quan‐yao Li, Wen‐xiao Yang, Hui Liu, Jia‐lin Yao, Qin Wang, Dan Lin, Jun Shi
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Cancer Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Trends in primary care blood tests prior to lung and colorectal cancer diagnosis—A retrospective cohort study using linked Australian data
di: Meena Rafiq, et al.
Pubblicazione: (2024)

Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer
di: Yuxuan Hao, et al.
Pubblicazione: (2024)

Immunotherapy combined with antiangiogenic therapy as third‐ or further‐line therapy for stage IV non‐small cell lung cancer patients with ECOG performance status 2: A retrospective study
di: Shuo Li, et al.
Pubblicazione: (2024)

Ultrahypofractionation in postoperative radiotherapy for breast cancer: A single‐institution retrospective cohort series
di: Angel Calvo Tudela, et al.
Pubblicazione: (2024)

Survival and safety analysis of COVID‐19 vaccine in Chinese patients with non‐small cell lung cancer
di: Wei Xu, et al.
Pubblicazione: (2024)

Potentially functional variants of ERRFI1 in hypoxia‐related genes predict survival of non‐small cell lung cancer patients
di: Huilin Wang, et al.
Pubblicazione: (2024)

Treatment preferences among Japanese patients and physicians for epidermal growth factor receptor‐mutant non‐small cell lung cancer
di: Akito Hata, et al.
Pubblicazione: (2024)

On the informative value of community‐based indoor radon values in relation to lung cancer
di: Albert Rosenberger, et al.
Pubblicazione: (2024)

Relationship between educational level and survival of patients with cancer: A multicentre cohort study
di: Xiao‐Yue Liu, et al.
Pubblicazione: (2024)

Cost‐effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR‐mutated advanced non‐small cell lung cancer
di: Wentao Tian, et al.
Pubblicazione: (2024)

Impact of immune‐related adverse events on survival outcomes in extensive‐stage small cell lung cancer patients treated with immune checkpoint inhibitors
di: Tadashi Nishimura, et al.
Pubblicazione: (2024)

Global burden of lung cancer in women of childbearing age attributable to ambient particulate matter pollution: 1990–2021
di: Ying‐da Song, et al.
Pubblicazione: (2024)

Exploring the symptoms and psychological experiences among lung cancer convalescence patients after radical lobectomy: A qualitative study
di: Julan Xiao, et al.
Pubblicazione: (2024)

Participant factors associated with psychosocial impacts of lung cancer screening: A systematic review
di: Kathleen McFadden, et al.
Pubblicazione: (2024)

Incidence of skeletal‐related events in patients with Ewing sarcoma: An observational retrospective study in Japan
di: Hisaki Aiba, et al.
Pubblicazione: (2024)

Incidence and risk factors of immune‐related adverse events induced by immune checkpoint inhibitors among older adults with non‐small cell lung cancer
di: Yiran Rong, et al.
Pubblicazione: (2024)

Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study
di: Yi Zheng, et al.
Pubblicazione: (2024)

The effect of self‐designed metabolic equivalent exercises on cancer‐related fatigue in patients with gastric cancer: A randomized controlled trial
di: Xiao Xin, et al.
Pubblicazione: (2024)

Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis
di: Wu Quanyang, et al.
Pubblicazione: (2024)

Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis
di: So Yon Jun, et al.
Pubblicazione: (2024)

Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study
di: Cheng‐Lung Hsu, et al.
Pubblicazione: (2024)

PD‐L1 inhibitors combined with whole brain radiotherapy in patients with small cell lung cancer brain metastases: Real‐world evidence
di: Litang Huang, et al.
Pubblicazione: (2024)

East Asian patients who received immunotherapy‐based therapy associated with improved survival benefit in advanced non‐small cell lung cancer: An updated meta‐analysis
di: Yueyuan Yao, et al.
Pubblicazione: (2024)

Preservation of cfRNA in cytological supernatants for cfDNA & cfRNA double detection in non‐small cell lung cancer patients
di: Yidan Ma, et al.
Pubblicazione: (2024)

Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants
di: Tasuku Nakabori, et al.
Pubblicazione: (2024)

Post‐acute sequelae of COVID‐19 in cancer patients: Two cohorts in UK and Hong Kong
di: Eric Yuk Fai Wan, et al.
Pubblicazione: (2024)

Common patient‐reported sources of cancer‐related distress in adults with cancer: A systematic review
di: Jennifer M. Stevens, et al.
Pubblicazione: (2024)

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD‐1/L1 therapy
di: Yuguang Zhao, et al.
Pubblicazione: (2024)

Risk factors for lenvatinib‐induced palmar‐plantar erythrodysesthesia syndrome in patients with hepatocellular carcinoma: A retrospective study
di: Shusuke Uekusa, et al.
Pubblicazione: (2024)

Schizandrin A induces non‐small cell lung cancer apoptosis by suppressing the epidermal growth factor receptor activation
di: Linhai Zhu, et al.
Pubblicazione: (2024)

Urban relatives ameliorate survival disparities for genitourinary cancer in rural patients
di: Mouneeb Choudry, et al.
Pubblicazione: (2024)

A qualitative study on redefining normality in relatives of patients with advanced cancer
di: Helen P. A. Driessen, et al.
Pubblicazione: (2024)

An analysis of the relationship of triglyceride glucose index with gastric cancer prognosis: A retrospective study
di: Chao Cai, et al.
Pubblicazione: (2024)

Why is end‐of‐life inpatient cost high among cancer patients? A prospective cohort study
di: Ishwarya Balasubramanian, et al.
Pubblicazione: (2024)

Phase Ib/II study on the safety, tolerability, and preliminary efficacy of pegylated irinotecan (JK1201I) as second‐line monotherapy for patients with small‐cell lung cancer
di: Jieran Long, et al.
Pubblicazione: (2024)

Investigating the determinants of fear of cancer recurrence in patients with early‐stage non‐small cell lung cancer: Insights from a restricted cubic spline model
di: Man Liu, et al.
Pubblicazione: (2024)

A large‐scale, multicenter characterization of BRAF G469V/A‐mutant non‐small cell lung cancer
di: Han Wu, et al.
Pubblicazione: (2024)

Combination tumor‐treating fields treatment for patients with metastatic non‐small cell lung cancer: A cost‐effectiveness analysis
di: Kun Liu, et al.
Pubblicazione: (2024)

Correction to A qualitative study on redefining normality in relatives of patients with advanced cancer
Pubblicazione: (2024)

Genomic heterogeneity of multiple synchronous lung cancers in Chinese population
di: Lei Zhao, et al.
Pubblicazione: (2024)